Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
On this week’s podcast, Medtech Insight’s Sue Darcey and Shawn M. Schmitt discuss an intriguing analysis of legislation that could be completed in 2018 that will likely impact the medtech industry.
In this edition of Device Week, Medtech Insight’s Tina Tan chats to Marion Webb about key trends in orthopedic and spine procedures in the EU’s five key markets: Germany, France, UK, Spain and Italy. These include which procedures are expected to grow the fastest and why.
On this week's podcast, David Filmore discusses with Shawn M. Schmitt some of the important dynamics that will impact medtech regulations globally in 2018, with a focus on the US, Europe and Asia.
On this week's podcast, we discuss our latest MTI 100 rankings, providing a view on top revenue-getters in the medtech space, and we look at issues that are driving up and down movements on the list.
On this week’s podcast, we highlight an eye-opening study that shows that the chummier a device-maker is with US FDA investigators, the more likely it is that those firms will experience quality system troubles and face costly product recalls.
In this edition of Device Week, Tina Tan chats to Marion Webb about the ophthalmic surgical devices market, specifically the smallest but fastest-growing segment of micro-invasive glaucoma surgery (MIGS) devices. Marion gives an insight into some of the emerging players in this space and the feedback from clinicians who have used MIGS devices in their practice.
In this week's podcast, Medtech Insight's Amanda Maxwell talks about where things stand and the big challenges ahead for implementation of the EU Medical Device and IVD Regulations.
On this week's podcast, we discuss some cases that might come up in the current session of the US Supreme Court and have an important impact on the device industry – in the realm of patent reviews, and consumer and state lawsuits.
In this edition of Device Week, Medtech Insight’s Tina Tan chats to Catherine Longworth about the recent surge in M&A deal-making and wonder if this would impact 2017’s overall outlook. They also chat about Merck’s ambitions to be an all-round leader in fertility treatment, for both drugs and devices and what makes Ireland continue to be an attractive medtech hub for generating innovation.
On this week’s podcast, we talk about how artificial intelligence is being used in the quality and regulatory arenas to review, sort and process big data to find quality systems or product problems.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.